45 results
8-K
EX-99.1
OCUL
Ocular Therapeutix Inc
4 Oct 23
Regulation FD Disclosure
9:02am
Mattessich President & Chief Executive Officer EURETINA Innovation Spotlight 4 th October 2023
2 Any statements in this presentation about future
8-K
u3x9fu zo4nhr
4 Oct 23
Regulation FD Disclosure
9:02am
PRE 14A
omuu8klme8ojl 3nldw
13 Apr 21
Preliminary proxy
5:07pm
8-K
EX-99.1
02uqyxxzw6r7qs3
11 Jan 21
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
35hvu1kpm5
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
EX-99.1
ir1 r1u21zyq9dv9
16 Jul 20
Results of Operations and Financial Condition
9:17am